Skip to main content
OpenTrials

Clinical trial condition

Triple Negative Breast Neoplasms

Explore clinical trials studying Triple Negative Breast Neoplasms. Study availability and eligibility vary by location and protocol.

846 public trials 302 recruiting studies
Refine in advanced search Browse all conditions

Triple Negative Breast Neoplasms trial results

Completed

Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer

NCT01091454

Conditions
Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +6 more
Locations
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Aurora Presbyterian Hospital Aurora, Colorado, United States
  • Boulder Community Hospital Boulder, Colorado, United States
  • Penrose Cancer Center at Penrose Hospital Colorado Springs, Colorado, United States
View all 266 locations
View Trial Details
Completed

Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment

NCT01520389

Conditions
Advanced Solid Tumors, Breast Diseases, Breast Neoplasms, +27 more
Locations
  • University of Colorado Denver Aurora, Colorado, United States
  • Horizon Oncology Research, Inc. Lafayette, Indiana, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • South Texas Accelerated Research Therapeutics, LLC (START) San Antonio, Texas, United States
View Trial Details
Completed

Veliparib and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer or Metastatic Breast Cancer

NCT01145430

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +30 more
Locations
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone New York, United States
  • Mount Sinai Hospital New York, United States
  • Columbia University/Herbert Irving Cancer Center New York, United States
  • Weill Medical College of Cornell University New York, United States
View Trial Details
Completed

Safety, Pharmacokinetics (PK) of AKT and MEK Combination

NCT01138085

Conditions
Breast Diseases, Breast Neoplasms, Cancer, +15 more
Locations
  • GSK Investigational Site Aurora, Colorado, United States
  • GSK Investigational Site New Haven, Connecticut, United States
  • GSK Investigational Site Boston, Massachusetts, United States
  • GSK Investigational Site Boston, Massachusetts, United States
View Trial Details
Completed

Abraxane With or Without Tigatuzumab in Patients With Metastatic, Triple Negative Breast Cancer

NCT01307891

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations
  • University of Alabama at Birmingham (UAB) Birmingham, Alabama, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • University of Chicago Chicago, Illinois, United States
  • Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
View Trial Details

Related conditions